| Antifungal drug resistance: evolution, mechanisms and impact |
51 |
| The soil microbiome - from metagenomics to metaphenomics |
44 |
| Low diversity gut microbiota dysbiosis: drivers, functional implications and recovery |
39 |
| Global epidemiology of emerging Candida auris |
35 |
| Klebsiella pneumoniae as a key trafficker of drug resistance genes from environmental to clinically important bacteria |
34 |
| New aspects of RNA-based regulation by Hfq and its partner sRNAs |
29 |
| Antibiotics: past, present and future |
26 |
| Evolution of virulence in Enterococcus faecium, a hospital-adapted opportunistic pathogen |
21 |
| Early life colonization of the human gut: microbes matter everywhere |
20 |
| Candida albicans biofilm growth and dispersal: contributions to pathogenesis |
19 |
| Candidalysin: discovery and function in Candida albicans infections |
19 |
| Sphingolipids in host-microbial interactions |
19 |
| Cross-kingdom RNA trafficking and environmental RNAi - natures blueprint for modern crop protection strategies |
19 |
| Metabolic heterogeneity in clonal microbial populations |
19 |
| Stimulus sensing and signal processing in bacterial chemotaxis |
18 |
| RiPP antibiotics: biosynthesis and engineering potential |
18 |
| Stronger together? Perspectives on phage-antibiotic synergy in clinical applications of phage therapy |
17 |
| Lifestyle transitions and adaptive pathogenesis of Pseudomonas aeruginosa |
17 |
| Survival of microbes in Earth's stratosphere |
16 |
| Recent advances in activating silent biosynthetic gene clusters in bacteria |
16 |
| Crying out for help with root exudates: adaptive mechanisms by which stressed plants assemble health-promoting soil microbiomes |
16 |
| Recent and emerging technologies for the rapid diagnosis of infection and antimicrobial resistance |
15 |
| Parasitic nematodes manipulate plant development to establish feeding sites |
15 |
| Mechanisms of biofilm stimulation by subinhibitory concentrations of antimicrobials |
15 |
| Beyond pathogens: microbiota interactions with the plant immune system |
15 |
| Evolution of virulence in the Mycobacterium tuberculosis complex |
14 |
| Microbiomes in extremely acidic environments: functionalities and interactions that allow survival and growth of prokaryotes at low pH |
14 |
| Microbial interactions trigger the production of antibiotics |
14 |
| Antibiotic efficacy in the complex infection environment |
14 |
| Unlocking the trove of metabolic treasures: activating silent biosynthetic gene clusters in bacteria and fungi |
13 |
| Opportunities for plant natural products in infection control |
13 |
| Bacterial microbiota of the nasal passages across the span of human life |
13 |
| The birth and death of effectors in rapidly evolving filamentous pathogen genomes |
13 |
| Colonization, localization, and inflammation: the roles of H-pylori chemotaxis in vivo |
12 |
| Functional roles and metabolic niches in the honey bee gut microbiota |
12 |
| Omics and multi-omics approaches to study the biosynthesis of secondary metabolites in microorganisms |
12 |
| Bacterial nanotubes: a conduit for intercellular molecular trade |
12 |
| Commensal Koch's postulates: establishing causation in human microbiota research |
12 |
| The mycobiota: fungi take their place between plants and bacteria |
11 |
| Reductionist synthetic community approaches in root microbiome research |
11 |
| Microbial communities as dynamical systems |
11 |
| Helminth extracellular vesicles in host-parasite interactions |
11 |
| Show me the way: rust effector targets in heterologous plant systems |
11 |
| Fungal effectors at the crossroads of phytohormone signaling |
10 |
| Molecular and cellular interactions defining the tropism of Plasmodium vivax for reticulocytes |
10 |
| Genome mining and prospects for antibiotic discovery |
10 |
| Tracing the evolutionary routes of plant-microbiota interactions |
9 |
| The evolution and transmission of multi-drug resistant Escherichia coil and Klebsiella pneumoniae: the complexity of clones and plasmids |
9 |
| Natural products discovery and potential for new antibiotics |
9 |
| Regulatory mechanisms controlling morphology and pathogenesis in Candida albicans |
9 |
